ID   MSL2_DROME              Reviewed;         773 AA.
AC   P50534; Q9VQR1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 2.
DT   22-JUL-2015, entry version 117.
DE   RecName: Full=E3 ubiquitin-protein ligase msl-2;
DE            EC=6.3.2.-;
DE   AltName: Full=Protein male-specific lethal-2;
GN   Name=msl-2; ORFNames=CG3241;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, INTERACTION WITH MSL-1,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=7781064; DOI=10.1016/0092-8674(95)90007-1;
RA   Kelley R.L., Solovyeva I., Lyman L.M., Richman R., Solovyev V.,
RA   Kuroda M.I.;
RT   "Expression of msl-2 causes assembly of dosage compensation regulators
RT   on the X chromosomes and female lethality in Drosophila.";
RL   Cell 81:867-877(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, INTERACTION WITH MSL-1,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=7796814;
RA   Zhou S., Yang Y., Scott M.J., Pannuti A., Fehr K.C., Eisen A.,
RA   Koonin E.V., Fouts D.L., Wrightsman R., Manning J.E., Lucchesi J.C.;
RT   "Male-specific lethal 2, a dosage compensation gene of Drosophila,
RT   undergoes sex-specific regulation and encodes a protein with a RING
RT   finger and a metallothionein-like cysteine cluster.";
RL   EMBO J. 14:2884-2895(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, INTERACTION WITH MSL-1,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=7588059;
RA   Bashaw G.J., Baker B.S.;
RT   "The msl-2 dosage compensation gene of Drosophila encodes a putative
RT   DNA-binding protein whose expression is sex specifically regulated by
RT   Sex-lethal.";
RL   Development 121:3245-3258(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [7]
RP   FUNCTION AS E3 UBIQUITIN LIGASE.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin
RT   ligase for H2B K34 and is involved in crosstalk with H3 K4 and K79
RT   methylation.";
RL   Mol. Cell 43:132-144(2011).
CC   -!- FUNCTION: The Msl proteins are essential for elevating
CC       transcription of the single X chromosome in the male (X chromosome
CC       dosage compensation). Msl-2 is required for translation and/or
CC       stability of msl-1 in males. In complex with msl-1, acts as an E3
CC       ubiquitin ligase that promotes ubiquitination of histone H2B.
CC       {ECO:0000269|PubMed:21726816, ECO:0000269|PubMed:7588059,
CC       ECO:0000269|PubMed:7781064, ECO:0000269|PubMed:7796814}.
CC   -!- SUBUNIT: Interacts with msl-1 in a tight complex to form a dosage
CC       compensation protein complex. {ECO:0000269|PubMed:7588059,
CC       ECO:0000269|PubMed:7781064, ECO:0000269|PubMed:7796814}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Msl-1 and msl-2
CC       colocalize to many sites on the male X chromosome.
CC   -!- DEVELOPMENTAL STAGE: Only produced in males.
CC   -!- SIMILARITY: Belongs to the MSL2 family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 RING-type zinc finger.
CC       {ECO:0000255|PROSITE-ProRule:PRU00175}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42553; AAA75573.1; -; Genomic_DNA.
DR   EMBL; Z48443; CAA88358.1; -; Genomic_DNA.
DR   EMBL; X89241; CAA61529.1; -; Genomic_DNA.
DR   EMBL; AE014134; AAF51104.1; -; Genomic_DNA.
DR   EMBL; AY128426; AAM75019.1; -; mRNA.
DR   PIR; S55554; S55554.
DR   RefSeq; NP_523467.1; NM_078743.5.
DR   RefSeq; NP_722907.1; NM_164536.2.
DR   UniGene; Dm.14311; -.
DR   PDB; 2LUA; NMR; -; A=520-570.
DR   PDB; 4RKG; X-ray; 2.50 A; A/B=520-570.
DR   PDB; 4RKH; X-ray; 2.00 A; C/D/E/F=520-570.
DR   PDBsum; 2LUA; -.
DR   PDBsum; 4RKG; -.
DR   PDBsum; 4RKH; -.
DR   ProteinModelPortal; P50534; -.
DR   SMR; P50534; 2-115, 520-569.
DR   BioGrid; 59776; 10.
DR   IntAct; P50534; 1.
DR   STRING; 7227.FBpp0077259; -.
DR   PaxDb; P50534; -.
DR   PRIDE; P50534; -.
DR   EnsemblMetazoa; FBtr0077570; FBpp0077259; FBgn0005616.
DR   EnsemblMetazoa; FBtr0077571; FBpp0077260; FBgn0005616.
DR   GeneID; 33565; -.
DR   KEGG; dme:Dmel_CG3241; -.
DR   CTD; 33565; -.
DR   FlyBase; FBgn0005616; msl-2.
DR   eggNOG; NOG86640; -.
DR   GeneTree; ENSGT00390000016814; -.
DR   InParanoid; P50534; -.
DR   KO; K13164; -.
DR   OMA; AYKVGSG; -.
DR   OrthoDB; EOG7BKCSX; -.
DR   PhylomeDB; P50534; -.
DR   GenomeRNAi; 33565; -.
DR   NextBio; 784222; -.
DR   PRO; PR:P50534; -.
DR   Proteomes; UP000000803; Chromosome 2L.
DR   Bgee; P50534; -.
DR   Genevisible; P50534; DM.
DR   GO; GO:0046536; C:dosage compensation complex; IDA:FlyBase.
DR   GO; GO:0072487; C:MSL complex; IDA:FlyBase.
DR   GO; GO:0000805; C:X chromosome; IDA:FlyBase.
DR   GO; GO:0016456; C:X chromosome located dosage compensation complex, transcription activating; NAS:FlyBase.
DR   GO; GO:0003682; F:chromatin binding; IDA:FlyBase.
DR   GO; GO:0003677; F:DNA binding; IDA:FlyBase.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008134; F:transcription factor binding; IPI:FlyBase.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:FlyBase.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007549; P:dosage compensation; IMP:FlyBase.
DR   GO; GO:0009047; P:dosage compensation by hyperactivation of X chromosome; NAS:FlyBase.
DR   GO; GO:0016457; P:dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome; TAS:FlyBase.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:FlyBase.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:FlyBase.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromosome; Coiled coil; Complete proteome; DNA-binding;
KW   Ligase; Metal-binding; Nucleus; Reference proteome;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    773       E3 ubiquitin-protein ligase msl-2.
FT                                /FTId=PRO_0000055962.
FT   ZN_FING      41     85       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   COILED      424    468       {ECO:0000255}.
FT   COMPBIAS    525    561       Cys-rich.
FT   COMPBIAS    685    713       Pro-rich.
FT   CONFLICT    280    280       T -> N (in Ref. 2; CAA88358).
FT                                {ECO:0000305}.
FT   CONFLICT    367    370       Missing (in Ref. 2). {ECO:0000305}.
FT   CONFLICT    371    373       VEE -> LKT (in Ref. 1; AAA75573).
FT                                {ECO:0000305}.
FT   CONFLICT    380    380       P -> Q (in Ref. 2; CAA88358).
FT                                {ECO:0000305}.
FT   CONFLICT    403    405       TQT -> IQA (in Ref. 2; CAA88358).
FT                                {ECO:0000305}.
FT   CONFLICT    423    423       H -> Q (in Ref. 3; CAA61529).
FT                                {ECO:0000305}.
FT   CONFLICT    429    429       Q -> H (in Ref. 2). {ECO:0000305}.
FT   CONFLICT    431    433       AES -> EEP (in Ref. 2 and 3).
FT                                {ECO:0000305}.
FT   CONFLICT    439    439       E -> V (in Ref. 2; CAA88358).
FT                                {ECO:0000305}.
FT   CONFLICT    443    443       A -> P (in Ref. 2; CAA88358).
FT                                {ECO:0000305}.
FT   CONFLICT    471    471       T -> A (in Ref. 3; CAA61529).
FT                                {ECO:0000305}.
FT   CONFLICT    591    591       M -> L (in Ref. 3; CAA61529).
FT                                {ECO:0000305}.
FT   CONFLICT    642    642       E -> D (in Ref. 2; CAA88358).
FT                                {ECO:0000305}.
FT   STRAND      530    533       {ECO:0000244|PDB:4RKG}.
FT   HELIX       535    537       {ECO:0000244|PDB:4RKH}.
FT   TURN        538    540       {ECO:0000244|PDB:2LUA}.
FT   HELIX       545    548       {ECO:0000244|PDB:4RKH}.
SQ   SEQUENCE   773 AA;  84856 MW;  31830142AD64F4D7 CRC64;
     MAQTAYLKVT RIAMRSASNL SKRRVEELNS GLGELRQLLS CVVCCQLLVD PYSPKGKRCQ
     HNVCRLCLRG KKHLFPSCTQ CEGCSDFKTY EENRMMAAQL LCYKTLCVHL LHSALFGELA
     GMRPQVAREL VPRIKLPPKT TQEFIREGSN ISDTFDIFLP QPDLPFLKDM PTSLPAETPP
     TSAVTTPELP YDHHLNISDI EAEAAATAEQ GHFSPLPLLP TGSRMGMLSH AGQIVIATES
     SESGFMDQAW TDQVDLSGTV SVSKYTNSGN NFAVSYVMPT SATTKFDPQE LQIGQVVQMA
     DSTQLAVLAA VEETVETSTQ LTVLSTTVEE TVETSTQLEV LTSAEEPNEI SDQLANLQVE
     ESDEALVEET VEEAEGTSIP SEVVAEHMEE DQHLDVHTSQ SPTQTEMEEA VEEHVATKTQ
     LGHVQTELQD AESLQKDFED AKAAAEEAKE KEKDLHAISA ELQKEDSDEP TLKRKRTRTL
     KASQAAKIEP VPSEVKTKVQ SGKGALRRIR GKDKEEKVKP PKPKCRCGIS GSSNTLTTCR
     NSRCPCYKSY NSCAGCHCVC CKNPHKEDYV ESDEDDDLED FEMPKDVPEP MTQSEEPVVA
     EPRQEENSMA PPDSSAPISL VPLNNLQQSQ HPLVLVQNEK GEYQGFNIFQ GSKPLDPVTV
     GFTIRVQLQH TDGFGSLPQY AYIMPTIDPP NPPAPSLSPP PPPAPDREVI EPPAKKFRTS
     RTRRGRANFS ALDTVDELVS GGSRSNSAAG DRSSATDNAH SLFEEIMSGS DDL
//
